Featured Research

from universities, journals, and other organizations

Better ways to predict kidney disease risk for African Americans: Gene testing could help identify patients who need early treatment

Date:
October 14, 2011
Source:
American Society of Nephrology
Summary:
African Americans with certain gene variants develop non-diabetic kidney disease more often than expected. African Americans with these variants risk developing focal segmental glomerulosclerosis and HIV nephropathy in particular and may need dialysis at a young age. Screening for these variants could identify individuals who should receive kidney-protective treatments

Compared to European Americans, African Americans are four to five times more likely to develop kidney failure. Also, family members of African Americans with kidney failure have an increased risk of developing kidney failure, which suggests that genetics may play a role in this skewed risk between races. Previous studies identified variants in a gene called APOL1 that may play a role. The APOL1 gene creates a protein that is a component of HDL, or good cholesterol.

An upcoming issue of the Journal of the American Society Nephrology (JASN) presents new research on the link between these variants and kidney disease in African Americans. "The five articles published in this issue launch a new era in investigating the underlying risks for developing two very common and complex kidney diseases in African Americans," said Eric G. Neilson M. D., editor-in-chief of JASN. "Susceptibility variants such as those in the APOL1 gene give scientists new tools for diagnosing and understanding certain diseases, and they could eventually provide new targets for drug therapy."

The five studies' findings are summarized below.

Ali Gharavi, MD (Columbia University College of Physicians and Surgeons) and his colleagues examined APOL1 gene variants in 74 healthy African Americans and African Americans with various common kidney disorders: 44 with focal segmental glomerulosclerosis (FSGS, which is characterized by scarring of the kidneys), 21 with HIV-associated nephropathy (HIVAN, a secondary form of FSGS linked with HIV infection), and 32 with IgA nephropathy (which occurs when antibodies build up in the kidneys). Variants in the APOL1 gene often occurred in individuals with FSGS and HIVAN but not in those with IgA nephropathy. "This study confirms that genetic variation in the APOL1 gene is a major risk factor for two forms of kidney disease and that the risk imparted is significant enough that APOL1 testing may be used to determine people's risk for kidney failure," said Dr. Gharavi.

Jeffrey Kopp, MD (National Institutes of Health) and his team studied 271 African American cases of FSGS and HIVAN, 168 European American cases, and 939 healthy individuals. African Americans with variants in both copies of the APOL1 gene had a greatly increased risk of developing FSGS and HIVAN. Approximately 13% of African Americans (more than 3.5 million individuals) carry two APOL1 gene variants, and these individuals have a 4% risk during their lifetime of developing FSGS; those with untreated HIV have a 50% risk during their lifetime of developing HIVAN. "We also found that APOL1-associated FSGS tended to arise at an earlier age and to progress to kidney failure more rapidly than non-APOL1-associated FSGS," said Dr. Kopp.

Martin Pollak, MD (Beth Israel Deaconess Medical Center) and his group looked to see if APOL1 gene variants confer risks for other types of kidney disease among 2,867 African Americans. Nondiabetic individuals with two APOL1 gene variants had a four-fold increased risk of developing chronic kidney disease over nondiabetics without the gene variants. (No increased risk occurred among diabetics.) "Our research shows that APOL1 variants explain the difference between the high rate of kidney disease in African Americans compared with European Americans," said Dr. Pollak.

Dr. Pollak also collaborated with Ravi Thadhani, MD (Massachusetts General Hospital) and others to examine whether African Americans with APOL1 gene variants need dialysis to treat kidney failure at a younger age than those without the variants. Among 407 African Americans with kidney failure, individuals with two gene variants started dialysis at an average age of 49.0 years, compared with 55.9 years for those with one gene variant and 61.8 years for those with no variants. "We may be able to predict when Blacks with kidney disease will experience kidney failure well before it occurs," said Dr. Thadhani. These results suggest that patients with two variants may benefit from early therapies to protect their kidneys.

John Sedor, MD (Case Western Reserve University) and his collaborators examined individuals' kidney tissues and found that the protein created by the APOL1 gene resides in different regions of the kidney in patients with FSGS or HIVAN compared to individuals without kidney disease. "Its appearance in the walls of small arteries in the kidney that occurs only in disease suggests that blood vessels may have an underappreciated role in the development and progression of these diseases," said Dr. Sedor.

People inherit two copies of the APOL1 gene -- one from each parent. If they inherit only one copy with a variant, they are resistant to infections caused by a parasite endemic to Africa. For this reason, the variants are common in individuals with African ancestry. Unfortunately, if both copies of the APOL1 gene contain a variant, an individual has an increased risk of kidney failure.

The studies' results provide new information about kidney disease and point to the dangers that African Americans with APOL1 gene variants may face if steps are not taken to protect their kidneys. Early screening and treatment could potentially safeguard against kidney failure and early death for millions of individuals.


Story Source:

The above story is based on materials provided by American Society of Nephrology. Note: Materials may be edited for content and length.


Journal References:

  1. N. Papeta, K. Kiryluk, A. Patel, R. Sterken, N. Kacak, H. J. Snyder, P. H. Imus, A. N. Mhatre, A. K. Lawani, B. A. Julian, R. J. Wyatt, J. Novak, C. M. Wyatt, M. J. Ross, J. A. Winston, M. E. Klotman, D. J. Cohen, G. B. Appel, V. D. D'Agati, P. E. Klotman, A. G. Gharavi. APOL1 Variants Increase Risk for FSGS and HIVAN but Not IgA Nephropathy. Journal of the American Society of Nephrology, 2011; DOI: 10.1681/ASN.2011040434
  2. J. B. Kopp, G. W. Nelson, K. Sampath, R. C. Johnson, G. Genovese, P. An, D. Friedman, W. Briggs, R. Dart, S. Korbet, M. H. Mokrzycki, P. L. Kimmel, S. Limou, T. S. Ahuja, J. S. Berns, J. Fryc, E. E. Simon, M. C. Smith, H. Trachtman, D. M. Michel, J. R. Schelling, D. Vlahov, M. Pollak, C. A. Winkler. APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy. Journal of the American Society of Nephrology, 2011; DOI: 10.1681/ASN.2011040388
  3. D. J. Friedman, J. Kozlitina, G. Genovese, P. Jog, M. R. Pollak. Population-based Risk Assessment of APOL1 on Renal Disease. Journal of the American Society of Nephrology, 2011; DOI: 10.1681/ASN.2011050519
  4. Z. Kanji, C. E. Powe, J. B. Wenger, C. Huang, E. Ankers, D. A. Sullivan, G. Collerone, N. R. Powe, M. Tonelli, I. Bhan, A. J. Bernhardy, S. DiBartolo, D. Friedman, G. Genovese, M. R. Pollak, R. Thadhani. Genetic Variation in APOL1 Associates with Younger Age at Hemodialysis Initiation. Journal of the American Society of Nephrology, 2011; DOI: 10.1681/ASN.2010121234
  5. S. M. Madhavan, J. F. O'Toole, M. Konieczkowski, S. Ganesan, L. A. Bruggeman, J. R. Sedor. APOL1 Localization in Normal Kidney and Nondiabetic Kidney Disease. Journal of the American Society of Nephrology, 2011; DOI: 10.1681/ASN.2011010069

Cite This Page:

American Society of Nephrology. "Better ways to predict kidney disease risk for African Americans: Gene testing could help identify patients who need early treatment." ScienceDaily. ScienceDaily, 14 October 2011. <www.sciencedaily.com/releases/2011/10/111014080533.htm>.
American Society of Nephrology. (2011, October 14). Better ways to predict kidney disease risk for African Americans: Gene testing could help identify patients who need early treatment. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2011/10/111014080533.htm
American Society of Nephrology. "Better ways to predict kidney disease risk for African Americans: Gene testing could help identify patients who need early treatment." ScienceDaily. www.sciencedaily.com/releases/2011/10/111014080533.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins